2,302
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Transdermal delivery system of nanostructured lipid carriers loaded with Celastrol and Indomethacin: optimization, characterization and efficacy evaluation for rheumatoid arthritis

, , , , , , & show all
Pages 585-597 | Received 20 Jun 2018, Accepted 17 Jul 2018, Published online: 11 Oct 2018

References

  • Doss HM, Ganesan R, Rasool M. Trikatu, an herbal compound ameliorates rheumatoid arthritis by the suppression of inflammatory immune responses in rats with adjuvant-induced arthritis and on cultured fibroblast like synoviocytes via the inhibition of the NFκB signaling pathway. Chem-Biol Interact. 2016;258:175–186.
  • Venkatesha SH, Astry B, Nanjundaiah SM, et al. Suppression of autoimmune arthritis by Celastrus-derived Celastrol through modulation of pro-inflammatory chemokines. Bioorg Med Chem. 2012;20:5229–5234.
  • Cascão R, Vidal B, Raquel H, et al. Effective treatment of rat adjuvant-induced arthritis by Celastrol. Autoimmun Rev. 2012;11:856–862.
  • Vitorino C, Almeida J, Gonçalves LM, et al. Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail. J Control Release. 2013;167:301–314.
  • Wissing SA, Müller RH. Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm. 2003;254:65.
  • Khurana S, Jain NK, Bedi PMS. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci. 2013;92:383–392.
  • Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci. 2006;123–126:369–385.
  • Shakeel F, Baboota S, Ahuja A, et al. Skin permeation mechanism of aceclofenac using novel nanoemulsion formulation. Pharmazie. 2008;63:580–584.
  • Su R, Fan W, Yu Q, et al. Size-dependent penetration of nanoemulsions into epidermis and hair follicles: implications for transdermal delivery and immunization. Oncotarget. 2017;8: 38214–38226.
  • Garg NK, Singh B, Tyagi RK, et al. Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model. Colloids Surf B: Biointerfaces. 2016;147:17–24.
  • Chen Y, Zhou L, Yuan L, et al. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers. Int J Nanomedicine. 2012;7:3023–3033.
  • Guo T, Zhang Y, Li Z, et al. Microneedle-mediated transdermal delivery of nanostructured lipid carriers for alkaloids from Aconitum sinomontanum. Artif Cells Nanomedicine Biotechnol. 2017;1–11.DOI:10.1080/21691401.2017.1376676
  • Ghate VM, Lewis SA, Prabhu P, et al. Nanostructured lipid carriers for the topical delivery of tretinoin. Eur J Pharm Biopharm. 2016;108:253–261.
  • Moghddam SM, Ahad A, Aqil M, et al. Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box–Behnken design approach. Artif Cells Nanomed Biotechnol. 2017;45(3):617–624.
  • Kumar A, Pathak K, Bali V. Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discov Today. 2012;17:1233–1241.
  • Hu X, Fan W, Yu Z, et al. Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery. Nanoscale. 2016;8:7024–7035.
  • Xie Y, Hu X, He H, et al. Tracking translocation of glucan microparticles targeting M cells: implications for oral drug delivery. J Mater Chem B. 2016;4:2864–2873.
  • Hu X, Zhang J, Yu Z, et al. Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers. Nanomedicine. 2015;11:1939–1948.
  • Wang X, Xue M, Gu J, et al. Transdermal microemulsion drug delivery system for impairing male reproductive toxicity and enhancing efficacy of Tripterygium Wilfordii Hook f. Fitoterapia. 2012;83:690–698.
  • Jia M, Deng C, Luo J, et al. A novel dexamethasone-loaded liposome alleviates rheumatoid arthritis in rats. Int J Pharm. 2018;540:57–64.
  • Kaur A, Bhoop BS, Chhibber S, et al. Supramolecular nano-engineered lipidic carriers based on diflunisal-phospholipid complex for transdermal delivery: QbD based optimization, characterization and preclinical investigations for management of rheumatoid arthritis. Int J Pharm. 2017;533:206–224.
  • Zeb A, Qureshi OS, Yu C-H, et al. Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. Int J Pharm. 2017;525:92–100.
  • Joshi SA, Jalalpure SS, Kempwade AA, et al. Fabrication and in-vivo evaluation of lipid nanocarriers based transdermal patch of colchicine. J Drug Deliv Sci Technol. 2017;41:444–453.
  • Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328:191–195.
  • Castro GA, Coelho ALLR, Oliveira CA, et al. Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Int J Pharm. 2009;381:77–83.
  • Pu Y, Cao D, Xie C, et al. Anti-arthritis effect of a novel quinazoline derivative through inhibiting production of TNF-α mediated by TNF-α converting enzyme in murine collagen-induced arthritis model. Biochem Biophys Res Commun. 2015;462:288–293.
  • Wu Q, Wang Y, Wang Q, et al. The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway. Immunol Lett. 2016;179:68–79.
  • Riley JL, Cruz-Almeida Y, Dasilva Ribeiro MC, et al. Age differences in the time course and magnitude of changes in circulating neuropeptides after pain evocation in humans. J Pain. 2017;18:1078–1086.
  • Zheng B, Hu L, Song X, et al. Analgesic effect of different moxibustion durations in rheumatoid arthritis rats. J Trad Chin Med. 2014;34:90–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.